{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:03:44Z","timestamp":1792800224231,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Medical Scientific Research Foundation of Guangdong Province","award":["B2025041"],"award-info":[{"award-number":["B2025041"]}]},{"name":"the Discipline Construction Fund of Zhanjiang Central Hospital, Guangdong Medical University","award":["2022A03"],"award-info":[{"award-number":["2022A03"]}],"id":[{"id":"https:\/\/ror.org\/04k5rxe29","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01496-3","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:35:23Z","timestamp":1778664923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TRMT6\/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression"],"prefix":"10.1186","volume":"32","author":[{"given":"Zhirong","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aorong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"ChengZhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"D Hner","year":"2022","unstructured":"Hner D, Wei H, Appelbaum AH FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"1496_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020;383:617\u201329.","journal-title":"N Engl J Med"},{"key":"1496_CR3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"1496_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood.2019003988","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Tiong IS, Quaglieri A, et al. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. Blood. 2020;135:791\u2013803.","journal-title":"Blood"},{"key":"1496_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Sci (New York N Y). 2018;361:1346\u20139.","journal-title":"Sci (New York N Y)"},{"key":"1496_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control. Nature. 2017;552:126\u201331.","journal-title":"Nature"},{"key":"1496_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"1496_CR8","doi-asserted-by":"publisher","first-page":"115661","DOI":"10.1016\/j.celrep.2025.115661","volume":"44","author":"S Li","year":"2025","unstructured":"Li S, Liu Y, Wu X, et al. The m 5\u00a0C methyltransferase NSUN2 promotes progression of acute myeloid leukemia by regulating serine metabolism. Cell Rep (Cambridge). 2025;44:115661.","journal-title":"Cell Rep (Cambridge)"},{"key":"1496_CR9","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1101\/gad.12.23.3650","volume":"12","author":"J Anderson","year":"1998","unstructured":"Anderson J, Phan L, Cuesta R, et al. The essential Gcd10p-Gcd14p nuclear complex is required for 1-methyladenosine modification and maturation of initiator methionyl-tRNA. GENE DEV. 1998;12:3650\u201362.","journal-title":"GENE DEV"},{"key":"1496_CR10","doi-asserted-by":"publisher","first-page":"32562","DOI":"10.1038\/srep32562","volume":"6","author":"M Wang","year":"2016","unstructured":"Wang M, Zhu Y, Wang C, et al. Crystal structure of the two-subunit tRNA m(1)A58 methyltransferase TRM6-TRM61 from Saccharomyces cerevisiae. SCI REP-UK. 2016;6:32562.","journal-title":"SCI REP-UK"},{"key":"1496_CR11","doi-asserted-by":"publisher","first-page":"692130","DOI":"10.3389\/fmolb.2021.692130","volume":"8","author":"B Wang","year":"2021","unstructured":"Wang B, Niu L, Wang Z, Zhao Z. RNA m1A Methyltransferase TRMT6 Predicts Poorer Prognosis and Promotes Malignant Behavior in Glioma. Front Mol Biosci. 2021;8:692130.","journal-title":"Front Mol Biosci"},{"key":"1496_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40001-022-00951-1","volume":"28","author":"Y Ye","year":"2023","unstructured":"Ye Y, Liu M, Wu F, et al. TRMT6 promotes hepatocellular carcinoma progression through the PI3K\/AKT signaling pathway. EUR J MED RES. 2023;28:48.","journal-title":"EUR J MED RES"},{"key":"1496_CR13","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1038\/s41467-021-26718-6","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang J, Li X, et al. N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. NAT COMMUN. 2021;12:6314.","journal-title":"NAT COMMUN"},{"key":"1496_CR14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41467-022-29790-8","volume":"13","author":"Z Su","year":"2022","unstructured":"Su Z, Monshaugen I, Wilson B, et al. TRMT6\/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer. NAT COMMUN. 2022;13:2165.","journal-title":"NAT COMMUN"},{"key":"1496_CR15","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s43018-025-00977-4","volume":"6","author":"E Tao","year":"2025","unstructured":"Tao E, Wang Y, Tan J, et al. TRMT6-mediated tRNA m(1)A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression. Nat cancer. 2025;6:1458\u201376.","journal-title":"Nat cancer"},{"key":"1496_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","volume":"26","author":"MS Hayden","year":"2014","unstructured":"Hayden MS, Ghosh S. Regulation of NF-\u03baB by TNF family cytokines. SEMIN IMMUNOL. 2014;26:253\u201366.","journal-title":"SEMIN IMMUNOL"},{"key":"1496_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0092-8674(00)00126-4","volume":"103","author":"L Deng","year":"2000","unstructured":"Deng L, Wang C, Spencer E, et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000;103:351\u201361.","journal-title":"Cell"},{"key":"1496_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","volume":"15","author":"A Kanayama","year":"2004","unstructured":"Kanayama A, Seth RB, Sun L, et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. MOL CELL. 2004;15:535\u201348.","journal-title":"MOL CELL"},{"key":"1496_CR19","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/nsmb.1731","volume":"16","author":"Y Kulathu","year":"2009","unstructured":"Kulathu Y, Akutsu M, Bremm A, Hofmann K, Komander D. Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. NAT STRUCT MOL BIOL. 2009;16:1328\u201330.","journal-title":"NAT STRUCT MOL BIOL"},{"key":"1496_CR20","doi-asserted-by":"publisher","first-page":"e70522","DOI":"10.1111\/jcmm.70522","volume":"29","author":"M Wu","year":"2025","unstructured":"Wu M, Zhang Y, Wang X, Zhou Y. TAB2 Promotes Immune Escape and Chemoresistance Through NF-\u03baB Pathway Activation in Cervical Cancer. J CELL MOL MED. 2025;29:e70522.","journal-title":"J CELL MOL MED"},{"key":"1496_CR21","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3390\/cancers16142509","volume":"16","author":"BR Zaliunas","year":"2024","unstructured":"Zaliunas BR, Gedvilaite-Vaicechauskiene G, Kriauciuniene L, Tamasauskas A, Liutkeviciene R. Associations of TRAF2 (rs867186), TAB2 (rs237025), IKBKB (rs13278372) Polymorphisms and TRAF2, TAB2, IKBKB Protein Levels with Clinical and Morphological Features of Pituitary Adenomas. CANCERS. 2024;16:2509.","journal-title":"CANCERS"},{"key":"1496_CR22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41419-024-06803-6","volume":"15","author":"H Shen","year":"2024","unstructured":"Shen H, Yuan J, Tong D, et al. Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK\/p38 MAPK signaling. CELL DEATH DIS. 2024;15:438.","journal-title":"CELL DEATH DIS"},{"key":"1496_CR23","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41589-020-0601-2","volume":"16","author":"L Wang","year":"2020","unstructured":"Wang L, Song C, Wang N, et al. NADP modulates RNA m(6)A methylation and adipogenesis via enhancing FTO activity. NAT CHEM BIOL. 2020;16:1394\u2013402.","journal-title":"NAT CHEM BIOL"},{"key":"1496_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41419-020-2408-1","volume":"11","author":"S Li","year":"2020","unstructured":"Li S, Zhang Y, Wang N, et al. Pan-cancer analysis reveals synergistic effects of CDK4\/6i and PARPi combination treatment in RB-proficient and RB-deficient breast cancer cells. CELL DEATH DIS. 2020;11:219.","journal-title":"CELL DEATH DIS"},{"key":"1496_CR25","doi-asserted-by":"publisher","first-page":"9075","DOI":"10.1038\/s41467-025-64144-0","volume":"16","author":"Y Qian","year":"2025","unstructured":"Qian Y, Wu C, Wei S, et al. ALKBH8-mediated codon-specific translation promotes colorectal tumorigenesis. NAT COMMUN. 2025;16:9075.","journal-title":"NAT COMMUN"},{"key":"1496_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/0008-5472.CAN-21-4249","volume":"83","author":"Y Hong","year":"2023","unstructured":"Hong Y, Yang Z, Chen Y, et al. The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression. CANCER RES. 2023;83:845\u201360.","journal-title":"CANCER RES"},{"key":"1496_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molcel.2017.10.019","volume":"68","author":"X Li","year":"2017","unstructured":"Li X, Xiong X, Zhang M, et al. Base-Resolution Mapping Reveals Distinct m(1)A Methylome in Nuclear- and Mitochondrial-Encoded Transcripts. MOL CELL. 2017;68:993\u20131005.","journal-title":"MOL CELL"},{"key":"1496_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108:353\u201366.","journal-title":"Haematologica"},{"key":"1496_CR29","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","volume":"98","author":"ML Guzman","year":"2001","unstructured":"Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 2001;98:2301\u20137.","journal-title":"Blood"},{"key":"1496_CR30","doi-asserted-by":"publisher","first-page":"16220","DOI":"10.1073\/pnas.252462599","volume":"99","author":"ML Guzman","year":"2002","unstructured":"Guzman ML, Swiderski CF, Howard DS, et al. Preferential induction of apoptosis for primary human leukemic stem cells. P NATL ACAD SCI USA. 2002;99:16220\u20135.","journal-title":"P NATL ACAD SCI USA"},{"key":"1496_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303\u201322.","journal-title":"Nat Rev Cancer"},{"key":"1496_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrc.2016.27","volume":"16","author":"ML Truitt","year":"2016","unstructured":"Truitt ML, Ruggero D. New frontiers in translational control of the cancer genome. Nat Rev Cancer. 2016;16:288\u2013304.","journal-title":"Nat Rev Cancer"},{"key":"1496_CR33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41556-019-0319-0","volume":"21","author":"S Delaunay","year":"2019","unstructured":"Delaunay S, Frye M. RNA modifications regulating cell fate in cancer. NAT CELL BIOL. 2019;21:552\u20139.","journal-title":"NAT CELL BIOL"},{"key":"1496_CR34","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.cell.2016.05.046","volume":"165","author":"H Goodarzi","year":"2016","unstructured":"Goodarzi H, Nguyen HCB, Zhang S, Dill BD, Molina H, Tavazoie SF. Modulated Expression of Specific tRNAs Drives Gene Expression and Cancer Progression. Cell. 2016;165:1416\u201327.","journal-title":"Cell"},{"key":"1496_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2005.10.036","volume":"21","author":"A Alexandrov","year":"2006","unstructured":"Alexandrov A, Chernyakov I, Gu W, et al. Rapid tRNA decay can result from lack of nonessential modifications. MOL CELL. 2006;21:87\u201396.","journal-title":"MOL CELL"},{"key":"1496_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2014.08.011","volume":"158","author":"H Gingold","year":"2014","unstructured":"Gingold H, Tehler D, Christoffersen NR, et al. A dual program for translation regulation in cellular proliferation and differentiation. Cell. 2014;158:1281\u201392.","journal-title":"Cell"},{"key":"1496_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrm.2017.91","volume":"19","author":"G Hanson","year":"2018","unstructured":"Hanson G, Coller J. Codon optimality, bias and usage in translation and mRNA decay. Nat Rev Mol Cell Biol. 2018;19:20\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1496_CR38","first-page":"a32896","volume":"11","author":"N Robichaud","year":"2019","unstructured":"Robichaud N, Sonenberg N, Ruggero D, Schneider RJ. Translational Control in Cancer. CSH PERSPECT BIOL. 2019;11:a32896.","journal-title":"CSH PERSPECT BIOL"},{"key":"1496_CR39","doi-asserted-by":"crossref","unstructured":"Bosman MCJ, Schuringa JJ, Vellenga E. Constitutive NF-\u03baB activation in AML: Causes and treatment strategies. Critical reviews in oncology\/hematology 2016;98: 35\u201344.","DOI":"10.1016\/j.critrevonc.2015.10.001"},{"key":"1496_CR40","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","volume":"98","author":"ML Guzman","year":"2001","unstructured":"Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 2001;98:2301\u20137.","journal-title":"Blood"},{"key":"1496_CR41","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.20130990","volume":"211","author":"A Volk","year":"2014","unstructured":"Volk A, Li J, Xin J, et al. Co-inhibition of NF-\u03baB and JNK is synergistic in TNF-expressing human AML. J Exp Med. 2014;211:1093\u2013108.","journal-title":"J Exp Med"},{"key":"1496_CR42","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1182\/blood-2014-04-569780","volume":"124","author":"MCJ Bosman","year":"2014","unstructured":"Bosman MCJ, Schepers H, Jaques J, et al. The TAK1-NF-\u03baB axis as therapeutic target for AML. Blood. 2014;124:3130\u201340.","journal-title":"Blood"},{"key":"1496_CR43","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cell.2016.09.038","volume":"167","author":"F Liu","year":"2016","unstructured":"Liu F, Clark W, Luo G, et al. ALKBH1-Mediated tRNA Demethylation Regulates Translation. Cell. 2016;167:816\u201328.","journal-title":"Cell"},{"key":"1496_CR44","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/genes13050910","volume":"13","author":"H Jin","year":"2022","unstructured":"Jin H, Huo C, Zhou T, Xie S. m(1)A RNA Modification in Gene Expression Regulation. GENES-BASEL. 2022;13:910.","journal-title":"GENES-BASEL"},{"key":"1496_CR45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41586-018-0243-7","volume":"558","author":"F Rapino","year":"2018","unstructured":"Rapino F, Delaunay S, Rambow F, et al. Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature. 2018;558:605\u20139.","journal-title":"Nature"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01496-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01496-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01496-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:15:06Z","timestamp":1783397706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01496-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01496-3","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}